Description/Abstract
The COVID-19 pandemic has caused rising anxiety and a corresponding increase in benzodiazepine prescriptions. Experts worry that inconsistent access to physicians as a result of stay-at-home orders will lead dependent patients to seek counterfeit or street drugs if their prescriptions lapse. This brief discusses these repercussions and recommends approaches to monitor and support those suffering from anxiety.
Accessible Version
Document Type
Issue Brief
Keywords
anxiety, COVID19, coronavirus, anti-anxiety drugs, prescription drugs, mental health
Disciplines
Psychiatric and Mental Health | Substance Abuse and Addiction
Date
1-26-2021
For More Information
Acknowledgements
The authors would like to thank Megan Ray and Shannon Monnat for edits on previous drafts.
Recommended Citation
Atlas, Noah and McNeill Brown, Austin, "Anxious Times and Anxiety Drugs" (2021). Population Health Research Brief Series. 113.
https://surface.syr.edu/lerner/113
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
